Kathleen K Schoemaker's Net Worth

$328 Million

Who is Kathleen K Schoemaker?

Kathleen K Schoemaker has an estimated net worth of $328 Million. This is based on reported shares across multiple companies, which include CoLucid Pharmaceuticals, Inc., MARINUS PHARMACEUTICALS INC, GLAUKOS Corp, Atara Biotherapeutics, Inc., Aldeyra Therapeutics, Inc., aTYR PHARMA INC, OTONOMY, INC., Neothetics, Inc., Durata Therapeutics, Inc., CADENCE PHARMACEUTICALS INC, Regado Biosciences Inc, Esperion Therapeutics, Inc., Clovis Oncology, Inc., ALIMERA SCIENCES INC, Evoke Pharma Inc, VERACYTE, INC., Dicerna Pharmaceuticals Inc, Volcano Corp, Orexigen Therapeutics, Inc., ZOGENIX, INC., Northstar Neuroscience, Inc., INTRALASE CORP, IOMAI CORP, TANDEM DIABETES CARE INC, Vanda Pharmaceuticals Inc., NUVASIVE INC, Transcept Pharmaceuticals Inc, REVA Medical, Inc., SENOMYX INC, Ocera Therapeutics, Inc., Achaogen Inc, ACHILLION PHARMACEUTICALS INC, Celator Pharmaceuticals Inc, SANTARUS INC, Somaxon Pharmaceuticals, Inc., and SENORX INC.

SEC CIK

Kathleen K Schoemaker's CIK is 0001207789

Past Insider Trading and Trends

2010 was Kathleen K Schoemaker's most active year for acquiring shares with 36 total transactions. Kathleen K Schoemaker's most active month to acquire stocks was the month of October. 2014 was Kathleen K Schoemaker's most active year for disposing of shares, totalling 74 transactions. Kathleen K Schoemaker's most active month to dispose stocks was the month of October. 2011 saw Kathleen K Schoemaker paying a total of $26,590,082.18 for 7,499,108 shares, this is the most they've acquired in one year. In 2006 Kathleen K Schoemaker cashed out on 30,652,100 shares for a total of $51,028,309.20, their largest year based on trade value.